Plandai Biotechnology (PLPL) Financial Statements
32 Followers
Plandai Biotechnology Financial Overview
Plandai Biotechnology's market cap is currently $44.89K. The company's EPS TTM is $-0.00; its P/E ratio is -87.33; Plandai Biotechnology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.81M | $ -710.15K | $ -24.27K | $ -105.00K | $ 0.00 |
| EBITDA | $ 35.88M | $ -19.55M | $ 7.18M | $ -105.00K | $ 171.86K |
| Net Income | $ 16.03M | $ -19.80M | $ 6.82M | $ -397.00K | $ -83.48K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Assets | $ 100.00K | $ 0.00 | $ 0.00 | $ 7.26M | $ 7.26M |
| Total Debt | $ 155.00K | $ 50.17K | $ 114.96K | $ 7.03M | $ 21.67M |
| Net Debt | $ 155.00K | $ 50.17K | $ 114.96K | $ 7.03M | $ 21.67M |
| Total Liabilities | $ 155.00K | $ 442.64K | $ 1.53M | $ 9.17M | $ 26.24M |
| Stockholders' Equity | $ -55.00K | $ -442.64K | $ -1.53M | $ -9.17M | $ -16.93M |
| Cash Flow | |||||
| Free Cash Flow | $ 15.64M | $ 558.11K | $ 6.96M | $ -6.67K | $ 0.00 |
| Operating Cash Flow | $ 15.64M | $ 558.11K | $ 6.96M | $ -6.67K | $ 0.00 |
| Investing Cash Flow | $ -100.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -15.54M | $ 19.82M | $ 0.00 | $ 6.67K | $ 0.00 |
Currency in USD
